interventional cardiology
Adjust Font Size: Decrease Increase

Pre-Clinical Trial Results

Controlled and prolonged elution kinetics and efficient drug transfer to arteries.

MiStent DES's unique coating formulation and technology delivers a controlled and sustained release of a drug from a rapidly absorbing polymer. This differentiated method of target drug delivery has already shown promising results related to safety and prolonged elution kinetics in pre-clinical porcine trials.

Clinical significance in humans is unknown.

Caution: The Micell products described on this website are investigational devices that are not available for sale in any country.
Home | About Us | Therapeutic Focus | Product Pipeline | Technology | News | Terms of Use | Privacy Policy | Site Map
© 2012 Micell Technologies, Inc. All rights reserved.
"Micell" and "MiStent" are registered trademarks of Micell Technologies, Inc.